ACTIVE

FARMAZORG

Financial year 2025 · Closed on 31/12/2025

Net result95,7 k €-72,1 %over 1 year
Revenue19,5 M €+19,9 %over 1 year
Equity2,3 M €+4,3 %over 1 year
Workforce76,5 ETP+22,0 %over 1 year

Identity

Source · BCE/KBO

FARMAZORG is a Public limited company incorporated in 2010. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Oudenburg. It employs on average 76,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0828.830.158
Incorporation
19/08/2010
Legal form
Public limited company
Registered office
Brugsesteenweg 5
8460 Oudenburg · FlandreSee on map
Contributed capital
61 500,00 €
Latest accounts
31/12/2025
Average workforce
76,5 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 15 filings

Trend over 15 financial years

20252024202320222021
Income statement
Revenue19,5 M €16,3 M €–––
EBITDA770,4 k €919,5 k €842,4 k €1,4 M €980 k €
Operating result210,8 k €506,1 k €598,9 k €1,2 M €815,3 k €
Net result95,7 k €343,2 k €442,2 k €948,3 k €672,8 k €
Balance sheet
Equity2,3 M €2,2 M €2,2 M €1,8 M €1,2 M €
Total assets6,5 M €6,1 M €4,5 M €4,3 M €3,5 M €
Cash294,8 k €59,3 k €171,4 k €672,5 k €343,2 k €
Debts4,2 M €3,9 M €2,3 M €2,5 M €2,3 M €
Other
Workforce76,5 ETP62,7 ETP46,8 ETP38,3 ETP36,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 26 ended

Active mandates

Bobbie Pharmaceutical Services

Director · since 23 juin 2025 · until 26 juin 2031 · 0799.344.237

Represented by Philippe de Dijcker

Active
MEULEMEESTER STEVEN

Director · since 23 juin 2025 · until 26 juin 2031 · 0885.857.052

Represented by Steven Meulemeester

Active
VCP GP

Director · since 23 juin 2025 · until 26 juin 2031 · 1001.335.849

Represented by Stijn Nauts

Active
Vybros Capital Partners

Director · since 23 juin 2025 · until 26 juin 2031 · 1002.056.223

Represented by Guy Vande Vyvere

Active

Ended mandates

MEDIPACK

Managing director · since 10 octobre 2023 · 1000.190.655

Represented by PHILIPPE DE DIJCKER

Ended
J.H.S. CONSULT & INVEST

Director · since 09 octobre 2023 · 0700.394.537

Represented by STIJN NAUTS

Ended
Vybros Invest

Managing director · since 09 octobre 2023 · 0664.877.590

Represented by KRISTOF DOCKERS

Ended
MEULEMEESTER DIDRIK

Director · since 30 décembre 2020 · until 09 octobre 2023 · 0885.857.547

Represented by DIDRIK MEULEMEESTER

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date14/07/202629/08/202508/07/202410/07/202312/08/202205/07/2021
General meeting30/06/202626/03/202514/05/202409/05/202328/06/202210/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 15 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202530/06/202614/07/2026DutchPDF
Full model31/12/202426/03/202529/08/2025DutchPDF
Abridged model31/12/202314/05/202408/07/2024DutchPDF
Abridged model31/12/202209/05/202310/07/2023DutchPDF
Abridged model31/12/202128/06/202212/08/2022DutchPDF
Abridged model31/12/202010/05/202105/07/2021DutchPDF
Abridged model31/12/201922/06/202007/09/2020DutchPDF
Abridged model31/12/201821/06/201930/08/2019DutchPDF
Abridged model31/12/201719/07/201830/08/2018DutchPDF
Abridged model31/12/201630/08/201731/08/2017DutchPDF
Abridged model31/12/201521/06/201605/07/2016DutchPDF
Abridged model31/12/201422/06/201524/09/2015DutchPDF
Abridged model31/12/201321/06/201422/08/2014DutchPDF
Abridged model31/12/201221/06/201309/09/2013DutchPDF
Abridged model31/12/201121/06/201230/08/2012DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 26 ended

Active mandates

Bobbie Pharmaceutical Services

Director · since 23 juin 2025 · until 26 juin 2031 · 0799.344.237

Represented by Philippe de Dijcker

Active
MEULEMEESTER STEVEN

Director · since 23 juin 2025 · until 26 juin 2031 · 0885.857.052

Represented by Steven Meulemeester

Active
VCP GP

Director · since 23 juin 2025 · until 26 juin 2031 · 1001.335.849

Represented by Stijn Nauts

Active
Vybros Capital Partners

Director · since 23 juin 2025 · until 26 juin 2031 · 1002.056.223

Represented by Guy Vande Vyvere

Active

Ended mandates

MEDIPACK

Managing director · since 10 octobre 2023 · 1000.190.655

Represented by PHILIPPE DE DIJCKER

Ended
J.H.S. CONSULT & INVEST

Director · since 09 octobre 2023 · 0700.394.537

Represented by STIJN NAUTS

Ended
Vybros Invest

Managing director · since 09 octobre 2023 · 0664.877.590

Represented by KRISTOF DOCKERS

Ended
MEULEMEESTER DIDRIK

Director · since 30 décembre 2020 · until 09 octobre 2023 · 0885.857.547

Represented by DIDRIK MEULEMEESTER

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates24/02/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates30/06/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates17/05/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates24/10/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates20/01/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates20/01/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates27/07/2016
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other14/09/2010
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202595,7 k €↓
  2. 2024
    Annual accounts 2024343,2 k €↓
  3. 2023
    Annual accounts 2023442,2 k €↓
  4. 2022
    Annual accounts 2022948,3 k €↑
  5. 2021
    Annual accounts 2021672,8 k €↑
  6. 2020
    Annual accounts 2020287,7 k €↓
  7. 2019
    Annual accounts 2019290,9 k €↑
  8. 2018
    Annual accounts 2018112,9 k €↑
  9. 2017
    Annual accounts 201779,7 k €↑
  10. 2016
    Annual accounts 201636,1 k €↑
  11. 2015
    Annual accounts 201535,4 k €↑
  12. 2014
    Annual accounts 2014-33,1 k €↓
  13. 2013
    Annual accounts 20136,6 k €↓
  14. 2012
    Annual accounts 201265 k €↑
  15. 2011
    Annual accounts 201112,5 k €
  16. 19/08/2010
    IncorporationPublic limited company